日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

达雷妥尤单抗联合来那度胺作为新诊断多发性骨髓瘤移植后维持治疗：AURIGA 研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024025746
Badros, Ashraf; Foster, Laahn; Anderson, Larry D Jr; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Shah, Nina; Chung, Alfred; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Voorhees, Peter
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses

移植后新诊断的多发性骨髓瘤患者接受达雷妥尤单抗联合来那度胺维持治疗：AURIGA 亚组分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01355-0
Foster, Laahn; Anderson, Larry D Jr; Chung, Alfred; Chaulagain, Chakra P; Pettijohn, Erin; Cowan, Andrew J; Costello, Caitlin; Larson, Sarah; Sborov, Douglas W; Shain, Kenneth H; Silbermann, Rebecca; Voorhees, Peter; Krevvata, Maria; Pei, Huiling; Patel, Sharmila; Khare, Vipin; Cortoos, Annelore; Carson, Robin; Lin, Thomas S; Badros, Ashraf
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Staging FDG PET/CT prediction of bone marrow involvement by diffuse large B-cell lymphoma leading to delayed recognition of multiple myeloma

FDG PET/CT 分期预测弥漫性大B细胞淋巴瘤骨髓受累情况，导致多发性骨髓瘤的诊断延迟。

期刊:Journal of Hematopathology
影响因子:0.6
doi:10.1007/s12308-025-00667-1
Gibbs, Amanda C; Batchala, Prem P; Gottlieb, Chelsea E; Balle, Bryan O; Obiorah, Ifeyinwa E; Foster, Laahn H; Ayers, Emily C; Craig, Jeffrey W
B细胞
多发性骨髓瘤
淋巴瘤
骨髓瘤
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏